findmyKOL
Clinical trialNCT00023361CompletedInterventional

TBTC Study 23: Treatment of HIV-Related Tuberculosis Using a Rifabutin-Based Regimen

SponsorCenters for Disease Control and PreventionEnrollment215HIV InfectionsTuberculosis
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Primary objective: To determine the rate of confirmed treatment failure and relapse with an intermittent rifabutin-based regimen for the treatment of isoniazid and rifamycin-susceptible HIV-related tuberculosis (TB).

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • University of British Columbia

    Vancouver, British Columbia, Canada

  • University of Manitoba

    Winnipeg, Manitoba, Canada

  • Montreal Chest Institute Mcgill University

    Montreal, Quebec, Canada

United States
  • Central Arkansas Veterans Health System

    Little Rock, Arkansas, United States

  • la County/usc Medical Center

    Los Angeles, California, United States

  • University of California, San Francisco

    San Francisco, California, United States

  • Denver Department of Public Health and Hospitals

    Denver, Colorado, United States

  • Washington, D.C. Vamc

    Washington D.C., District of Columbia, United States

  • Chicago Va Medical Center (lakeside)

    Chicago, Illinois, United States

  • Hines Va Medical Center

    Hines, Illinois, United States

  • Johns Hopkins University School of Medicine

    Baltimore, Maryland, United States

  • Boston Medical Center

    Boston, Massachusetts, United States

  • New Jersey Medical School

    Newark, New Jersey, United States

  • Columbia University/presbyterian Medical Center

    New York, New York, United States

  • Harlem Hospital Center

    New York, New York, United States

  • New York University School of Medicine

    New York, New York, United States

  • Carolinas Medical Center

    Charlotte, North Carolina, United States

  • Duke University Medical Center

    Durham, North Carolina, United States

  • Nashville Va Medical Center

    Nashville, Tennessee, United States

  • University of North Texas Health Science Center

    Fort Worth, Texas, United States

  • Thomas Street Clinic

    Houston, Texas, United States

  • Audi L. Murphy Va Hospital

    San Antonio, Texas, United States

  • Seattle King County Health Department

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Feb 1999
Primary completion
—
Completion
28 Feb 2003
Last update posted
5 Sept 2005
Registered enrollment
215
Registry id
NCT00023361

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.